scispace - formally typeset
Open AccessJournal ArticleDOI

Cholesterol-Lowering Effect of Beta Glucan Extracted from Saccharomyces cerevisiae in Rats.

Kusmiati, +1 more
- 14 Feb 2016 - 
- Vol. 84, Iss: 1, pp 153-165
Reads0
Chats0
TLDR
Study reveal that soluble glucans can lower total cholesterol and LDL levels in patients with hypercholesterolemia and potential use of beta-glucan extract as an anticholesterol agent was tested using Sprague dawley strain rats.
Abstract
Glucans are present in fungi, plants, algae, and bacteria. β-Glucan, one of the major cell wall components of Saccharomyces cerevisiae, has been found to enhance immune functions. Glucans are glucose polymers with an α- or β-type glycosidic chain. The role of (1→3)-β-D-glucan is in the maintenance of yeast cell wall shape and rigidity. Studies reveal that soluble glucans can lower total cholesterol and LDL levels in patients with hypercholesterolemia. The important benefit of β-glucan is to improve the immune system and to decrease cholesterol levels in the blood. Several studies have reported the benefits of β-glucan as: antiseptic, antioxidant, anti-aging, immune system activators, protection against radiation, anti-inflammatory, anti-diabetic, anti-cholesterol etc. In this research S. cerevisiae was cultured in yeast extract-peptone-glucose (YPG) broth medium to produce beta-glucan. Cells were harvested at the stationary phase, washed, and disrupted by means of sonication method. The obtained cell walls were used to prepare alkali-soluble β-glucan (glucan-S1). In this regard, 2% sodium hydroxide (NaOH) and 3% acetic acid were used in alkaline-acid extraction, respectively. Potential use of beta-glucan extract as an anticholesterol agent was tested using Sprague dawley strain rats. The experiments were divided into eight groups with four replicates: Group I (normal control), group II (fed with cholesterol without beta-glucan), group III (fed with cholesterol + atorvastatin), group IV (fed with cholesterol + β-glucan standard), group V-VIII (fed of cholesterol + β-glucan of S. cerevisiae with each dose of 10, 20, 30, and 40 mg / BW. Rats were fed with cholesterol for 14 days, except for group I. Analysis of blood was carried out to determine total cholesterol, triglycerides, and malondialdehyde. The results showed that beta-glucan crude obtained from S. cerevisiae cultures was 6.890g.L(-1). Βeta-glucan extract of S. cerevisiae can reduce total cholesterol approaching normal values at doses of 10 mg of 32.79 % (blood plasma) and 33.71 % (in the liver). The extract was capable of reducing triglyceride levels in a dose of 10 mg of beta-glucan 64.43 % (blood plasma) and at a dose 30 mg of beta-glucan 19.45 % (liver). Beta-glucan treatment at a dose of 40 mg can reduce MDA levels of 45.22 % (blood plasma) and 42.64 % (liver).

read more

Citations
More filters
Journal ArticleDOI

Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future.

TL;DR: This review provides extensive data on the clinical study of β-glucans and compares their biological activities through the existing in vitro and animal-based in vivo studies.
Journal ArticleDOI

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials.

TL;DR: An up-to-date review of glucans (β-1,3-glucans) and their role in various immune reactions and the treatment of cancer.
Journal ArticleDOI

β-glucans and cholesterol (Review)

TL;DR: Evidence supporting the effects of β-glucans on cholesterol levels is discussed, which suggests they may be developed as a suitable therapeutic option to treat patients with dyslipidemia, as they are natural molecules that do not induce any significant side effects.
Journal ArticleDOI

Sustainable aquaculture and animal feed from microalgae – Nutritive value and techno-functional components

TL;DR: An overall view of the nutritional quality of microalgae and its beneficial application as a sustainable feed ingredient is provided, along with future research prospects.
Journal ArticleDOI

β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application

TL;DR: The biology, potential mechanisms of action and key therapeutic targets being investigated in clinical trials of β-glucans are described and the key challenges to successful translation of this intriguing potential therapeutic are identified.
References
More filters
Journal ArticleDOI

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

TL;DR: Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
Journal ArticleDOI

Structural mechanism for statin inhibition of HMG-CoA reductase.

TL;DR: The structures of the catalytic portion of human HMGR complexed with six different statins are determined, which show several catalytically relevant residues are disordered in the enzyme-statin complexes.
Journal ArticleDOI

Clinical Methods: The History, Physical, and Laboratory Examinations

Vivian L. Clark, +1 more
- 05 Dec 1990 - 
TL;DR: Clinical Methods, now in its third edition, reviews the history and physical examination in depth and offers brief discussions of selected laboratory methods used in diagnosis.
Journal ArticleDOI

Steroidogenic enzymes : structure, function, and role in regulation of steroid hormone biosynthesis

TL;DR: The final part of the review on regulation of steroidogenesis includes a description of the normal physiological fluctuations in the steroid output of adrenal cortex and gonads, and provides an analysis of the relative role of enzyme levels in the determination of these fluctuations.
Related Papers (5)